Equities are units of ownership in which investors can own through the purchase of stocks. Shareholders of equities are entitled to a company's assets and profits.
The Canadian Dollar remains intimately tied to the broad trends in investors' risk appetite, with prices continuing to show a strong correlation with the S&P 500. In fact, the relationship goes beyond USDCAD, with a trade-weighted index of the Canadian unit's average value against its leading counterparts likewise showing a significant relationship with the benchmark equity index.
Well known diagnostic chain Dr Lal PathLabs public issue will open on Dec 8th with a price band of Rs 540-Rs 550 on each equity share, valuing the company at Rs 4000cr. In this public offering, the promoters of Pathlabs, TA associates will dilute total of 14 per-cent stake from the company, which makes the total offer size in the range of Rs 620-630 cr. The organization said it is offering up to Rs 15 discount to retail investors.Click Here For Stock option tips
Precious metals seemed to lose their luster this week as investors attempted to sell off wins to account for the losers in their portfolio. With a seemingly declining value as a safe haven against the dollar the precious metal bull run of the last several months may be coming to an end.
The energy sector was broadly higher following a BP report that divided the blame over several major oil companies. The price of oil meanwhile, fell beneath $90 per gallon again today after reaching Tuesday highs in recent trading.
Hong Kong blue chips opened 65 points lower and continued to fall, dragged down by big declines in Chinese bank stocks. Worry about declining asset values hit big banks.
Investors are probing for a comfort level in stocks, but this means more volatility ahead for stocks. Stocks may see a short term rebound as investors shop for value buys.
Stocks opened higher today and have moved around in positive territory as investors feel for a bottom. Wall Street remains cautiously optimistic despite bearish economic outlook.
Wall Street jumped today as investors may be feeling for a bottom in the market, especially since the Federal Reserve is expected to address the possibility of additional economic stimulus.
Earnings can often be the best indicator of a company's health and the likelihood it has to continue on a given trajectory. These three companies appear to be primed for continued strength.
Finding a real winner can help any investor stay the course. Sometimes stocks appear like real winners but fade too quickly. One hit wonders can make you money sometimes, the goal is to find the Hall of Famer.
Energy stocks have been battered since April with the price of crude. Many are currently being offered up at dirt cheap levels in spite of plenty of technical indicators that oil shouldn't be down for long.
As the first new Lupus drug to debut in the last half-of-a-century, Benlysta has the potential to be something special. Reception of the drug from doctors has been lukewarm thus far, but with many other treatments associated with severe potential side effects, Benlysta may be a blockbuster nonetheless.
The Street awaits news from the Fed and Europe, the latter not expected now until early October. Beware of a new-prompted breakout above DJIA 11,740 (S&P 1220)
Companies, like SaviCorp., which are able to make a significant contribution to emission reduction without adding extra cost to the consumer may be positioned to thrive.
Recognizing the ongoing strength of gold in light of the tenuous economic nature of the moment, exploration outfit Red Metal Resources continues to pursue a strategy of aggressive growth.
Many investors seem to believe that gold is the ultimate hedge, but Michael McTague, in the interests of myth busting--and truth--gives a resounding "no."